Cited by 239Reproductive Health and ContraceptionEstrogen and related hormone effectsOvarian function and disorders

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins

Wiegratz, I., Kutschera, E., Lee, J.H., Moore, C., Mellinger, U., Winkler, U.H., Kuhl, H.·2003·Contraception

Open this paper in CoChat — free account

Abstract

In a double-blind, controlled, randomized, four-arm, bicentric clinical study, the effect of four oral contraceptives (OCs) on various hormone parameters and serum-binding globulins was investigated. Four groups with 25 volunteers each (18-35 years of age) were treated for six cycles with monophasic combinations containing 21 tablets with either 30 microg ethinylestradiol (EE) + 2 mg dienogest (DNG) (30EE/DNG), 20 microg EE + 2 mg DNG (20EE/DNG), 10 microg EE + 2 mg estradiol valerate (EV) + 2 mg DNG (EE/EV/DNG) or 20 microg EE + 100 microg levonorgestrel (LNG) (EE/LNG). The study was completed by 91 subjects. Blood samples were taken after at least 12 h of fasting on Day 21-26 of the preceding control cycle and on Day 18-21 of the first, third and sixth treatment cycle. The serum concentrations of free testosterone were significantly decreased by about 40-60% in all four groups, while those of dehydroepiandrosterone sulfate (DHEAS) showed a time-dependent decrease during treatment. Except for EE/EV/DNG, which increased prolactin significantly during the third and sixth cycles, no change was observed with the EE-containing preparations. There was a significant increase in the levels of serum-binding globulins during treatment, which differed according to the composition of the OCs used. The rise in sex hormone-binding globulin (SHBG) was highest during intake of 30EE/DNG (+320%) and lowest with EE/LNG (+80%), while the effect of 20EE/DNG and EE/EV/DNG was similar (+270%). The thyroxine-binding globulin (TBG) levels increased significantly, by 50-60%, during treatment with the DNG-containing formulations, while the effect of EE/LNG was less significant (+30%). The rise in corticosteroid-binding globulin (CBG), which occurred in all groups, was most pronounced in women treated with 30EE/DNG (+90%) and least with EE/EV/DNG (+55%), indicating a strong influence of EE and no effect of the progestogen component. In all treatment groups, the frequency of intracyclic bleeding rose in the first treatment cycle and decreased thereafter. Cycle control was significantly better with 30EE/DNG or EE/LNG than with 20EE/DNG or EE/EV/DNG. There was no significant change in blood pressure, body mass index or pulse rate throughout the study. In conclusion, the DNG-containing OCs caused a higher rise in SHBG and TBG levels than the LNG-containing preparation. The effects on CBG suggest a lesser hepatic effect of 2 mg EV as compared to 20 or 30 microg EE. In contrast to EE, the use of estradiol in OCs appeared to increase prolactin release, while the cycle control was better with the OC containing 30 microg EE.

Integrity signals

Registry

Crossref · 10.1016/s0010-7824(02)00436-5

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma
DUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238
Reduced Clearance Rate of Thyroxine-Binding Globulin (TBG) with Increased Sialylation: A Mechanism for Estrogen-Induced Elevation of Serum TBG Concentration*
Ain, K. B., MORI, Y., & Refetoff, S. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-4-689 · Cited by 310
Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone
van der Vange, N., Blankenstein, M. A., Kloosterboer, H. J., Haspels, A. A., & Thijssen, J. H. H. (1990) · Contraception · doi:10.1016/0010-7824(90)90034-s · Cited by 175
Oral contraceptives and myocardial infarction: results of the MICA case-control study Commentary: Oral contraceptives and myocardial infarction: reassuring new findings
Dunn, N., Thorogood, M., Faragher, B. E., de Caestecker, L., MacDonald, T. M., McCollum, C. N., Thomas, S., Mann, R., & Lidegaard, Ø. (1999) · BMJ · doi:10.1136/bmj.318.7198.1579 · Cited by 169
Changes in androgens during treatment with four low-dose contractptives
Coenen, C. M. H., Thomas, C. M. G., Borm, G. F., Hollanders, J. M. G., & Rolland, R. (1996) · Contraception · doi:10.1016/0010-7824(96)00006-6 · Cited by 144
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins
Wiegratz, I., Jung-Hoffmann, C., & Kuhl, H. (1995) · Contraception · doi:10.1016/0010-7824(95)00098-u · Cited by 115
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel
Hammond, G. L., Langley, M. S., Robinson, P. A., Nummi, S., & Lund, L. R. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47956-2 · Cited by 113
Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel
Gaspard, U., Romus, M. A., Gillain, D., Duvivier, J., Demey-Ponsart, E., & Franchimont, P. (1983) · Contraception · doi:10.1016/0010-7824(83)90023-9 · Cited by 104
Oral Contraceptives and Myocardial Infarction
Radford, D. J., & Oliver, M. F. (1973) · BMJ · doi:10.1136/bmj.3.5877.428 · Cited by 95
Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone
Jung-Hoffmann, C., & Kühl, H. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90238-9 · Cited by 76
Effects of oral contraceptive steroids on pituitary prolactin secretion
Abu-Fadil, S., DeVane, G. W., Siler, T. M., & Yen, S. S. C. (1976) · Contraception · doi:10.1016/0010-7824(76)90076-7 · Cited by 68
An in vivo system in man for quantitation of estrogenicity
Moore, D. E., Kawagoe, S., Davajan, V., Mishell, D. R., & Nakamura, R. M. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90293-4 · Cited by 64
A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives
Aden, U., Jung-Hoffmann, C., & Kühl, H. (1998) · Contraception · doi:10.1016/s0010-7824(98)00071-7 · Cited by 63
An in vivo system in man for quantitation of estrogenicity
Moore, D. E., Kawagoe, S., Davajan, V., Nakamura, R. M., & Mishell, D. R. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90294-6 · Cited by 57
THE OESTROGENIC POTENCY OF VARIOUS CONTRACEPTIVE STEROIDS AS DETERMINED BY THEIR EFFECTS ON TRANSCORTIN-BINDING CAPACITY
Schwartz, U., & Hammerstein, J. (1974) · European Journal of Endocrinology · doi:10.1530/acta.0.0760159 · Cited by 56
Effect of two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrel upon various hormonal parameters
Jung-Hoffmann, C., Heidt, F., & Kühl, H. (1988) · Contraception · doi:10.1016/0010-7824(88)90044-3 · Cited by 55
Effect of Oral Contraceptives on Plasma Androgenic Steroids and Their Precursors
Fern, M., Rose, D. P., & Fern, E. B. (1978) · Obstetrics and Gynecology · doi:10.1097/00006250-197805000-00005 · Cited by 51
Hyperprolactinemia and contraception: a prospective study.
Luciano, A. A., Sherman, B. M., Chapler, F. K., Hauser, K. S., & Wallace, R. B. (1985) · PubMed · Cited by 50
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels
Kühl, H., Gahn, G., Romberg, G., März, W., & Taubert, H. ‐. (1985) · Contraception · doi:10.1016/0010-7824(85)90058-7 · Cited by 46
Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: Serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum
Kuhnz, W., Staks, T., & Jütting, G. (1994) · Contraception · doi:10.1016/0010-7824(94)90014-0 · Cited by 45
Influence of Endometrial 17β-Hydroxysteroid Dehydrogenase Activity on the Binding of Estradiol to Receptors*
Gurpide, E., & Marks, C. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-2-252 · Cited by 44
Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel
Gaspard, U., Dubois, M., Gillain, D., Franchimont, P., & Duvivier, J. (1984) · Contraception · doi:10.1016/0010-7824(84)90064-7 · Cited by 43
Approaches to the replacement of ethinylestradiol by natural 17β-estradiol in combined oral contraceptives
Hoffmann, H., Moore, C., Zimmermann, H., Elger, W. A. G., Schwarz, S., Gräser, T., & Oettel, M. (1998) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(98)80034-1 · Cited by 43
ORAL CONTRACEPTIVE AGENTS DO NOT AFFECT SERUM PROLACTIN IN NORMAL WOMEN
Davis, J. R., Selby, C., & Jeffcoate, W. J. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb03438.x · Cited by 42
The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters
Kühl, H., Jung-Hoffmann, C., Weber, J., & Boehm, B. O. (1993) · Contraception · doi:10.1016/0010-7824(93)90109-k · Cited by 35
Elevation of serum prolactin during application of oral contraceptives
DERICKS-TAN, J. S. E., & Taubert, H. ‐. (1976) · Contraception · doi:10.1016/s0010-7824(76)80002-9 · Cited by 35
Oral contraceptive containing natural estradiol for premenopausal women
Hirvonen, E., Allonen, H. O., Anttila, M. P. V., Kulmala, Y., Ranta, T., Rautiainen, H., Sipilä, P., & Ylöstalo, P. (1995) · Maturitas · doi:10.1016/0378-5122(94)00856-3 · Cited by 33
Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin
Song, S. Y., Chen, J.-K., He, M.-L., & Fotherby, K. (1989) · Contraception · doi:10.1016/0010-7824(89)90117-0 · Cited by 31
Oral Contraceptives Containing 20 or 30 μg Ethinylestradiol and 150 μg Desogestrel: Pharmacokinetics and Pharmacodynamic Parameters
Jung-Hoffmann, C., Fitzner, M., & Kühl, H. (2008) · Hormone Research · doi:10.1159/000182172 · Cited by 29
Endometrial vascular changes and bleeding disturbances with long-acting progestins
Fraserab, I. (2000) · Steroids · doi:10.1016/s0039-128x(00)00188-4 · Cited by 29
Effects of the Estrogenicity of Levonorgestrel/Ethinylestradiol Combinations on the Lipoprotein Status
Larsson‐Cohn, U., Fåhraeus, L., Wallentin, L. C., & Zador, G. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209155316 · Cited by 29
Transport of steroid hormones
Vermeulen, A. (1976) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-02644-9_24 · Cited by 28
The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days
Csemiczky, G., Dieben, T. O. M., Bennink, H. J. T. C., & Landgren, B.-M. (1996) · Contraception · doi:10.1016/s0010-7824(96)00201-6 · Cited by 25
Validity of radioimmunological methods for determining free testosterone in serum
Gruschke, A., & Kühl, H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01939-2 · Cited by 24
Clinical and hormonal effects of two contraceptives: Correlation to serum concentrations of levonorgestrel and gestodene
Refn, H., Kjær, A., Lebech, A., Borggaard, B., & Schierup, L. (1990) · Contraception · doi:10.1016/0010-7824(90)90067-6 · Cited by 24
Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
Serup, J. V., Bostofte, E., Larsen, S., & Westergaard, J. H. (1981) · PubMed · Cited by 23
EFFECTIVITY AND ACCEPTABILITY OF ORAL CONTRACEPTIVES CONTAINING NATURAL AND ARTIFICIAL ESTROGENS IN COMBINATION WITH A GESTAGEN
Serup, J. V., Bostofte, E., Larsen, S., & Westergaard, J. H. (1981) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.1981.tb00038.x · Cited by 18
Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: Serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum
Kuhnz, W., Baumann, A., Staks, T., DIBBELT, L., Knuppen, R., & Jütting, G. (1993) · Contraception · doi:10.1016/0010-7824(93)90077-k · Cited by 17
Is the contraceptive effect of 300 μg of norethisterone mainly peripheral or central?
Kim-Björklund, T., Landgren, B.-M., & Hamberger, L. A. (1992) · Contraception · doi:10.1016/0010-7824(92)90141-f · Cited by 16
Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel
Jung-Hoffmann, C., Storch, A., & Kuhl, H. (2008) · Hormone Research · doi:10.1159/000182537 · Cited by 15

Research works printed but not linked: 2

Gaspard, 1983, Plasma hormone levels in women receiving new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel, Contraception, 27, 577, 10.1016/0010-7824(83)90023-9 · DOI
Luciano, 1985, Hyperprolactinemia and contraception, Obstet Gynecol, 63, 506

Sorted by citations

Salivary cortisol as a biomarker in stress research
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.026 · Cited by 1,925
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163
The effects of sex and hormonal status on the physiological response to acute psychosocial stress
Kajantie, E., & Phillips, D. I. W. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.07.002 · Cited by 1,035
“, 2002) and increases in particular during the use of oral contraceptives (Fujimoto et al., 1986; Wiegratz et al., 2003).”
Background
Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge
Kudielka, B. M., Hellhammer, D. H., & Wüst, S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.004 · Cited by 963
“…of a possibly modulating role of corticosteroid binding globulin since steroid binding globulin levels in the blood (including CBG) are significantly altered by intake of oral contraceptives containing the synthetic estradiol component ethinylestradiol (Moore et al., 1978; Wiegratz et al., 2003).”
Background
Oestrogen exposure and breast cancer risk
Travis, R. C., & Key, T. J. (2003) · Breast Cancer Research · doi:10.1186/bcr628 · Cited by 346
“of oral contraceptives than among those who were not [94,95].”
Background

See all 239

Authors: Wiegratz, I., Kutschera, E., Lee, J. H., Moore, C., Mellinger, U., Winkler, U. H., & Kuhl, H.
Affiliations: Goethe University Frankfurt (DE)
Venue: Contraception
Publisher: Elsevier BV
Published: 2003-01
Volume: 67
Issue: 1
Pages: 25-32
ISSN: 0010-7824 (ISSN-L)
DOI: 10.1016/s0010-7824(02)00436-5
OpenAlex: W2002526921
Cited by: 239
References: 40
Citations by year: 2026: 6 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 10 · 2020: 13 · 2019: 14 · 2018: 9 · 2017: 8 · 2016: 13 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 13
FWCI: 7.11
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Contraception (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords: oral contraceptives, sex hormones, sex hormone-binding globulin, ethinyl estradiol, dienogest, estradiol valerate, levonorgestrel, free testosterone, dehydroepiandrosterone sulfate, prolactin, thyroxine-binding globulin, corticosteroid-binding globulin
MeSH terms: Adolescent, Adult, Contraceptives, Oral, Double-Blind Method, Estradiol, Ethinyl Estradiol, Female, Humans, Nandrolone, Reference Values, Sex Hormone-Binding Globulin, Gonadal Steroid Hormones, Testosterone, Thyroxine-Binding Proteins, Treatment Outcome, Levonorgestrel, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks